The center has a standing Data Review Committee that can provide DSM for studies that do not need an independent DSMB, such as non-randomized early phase studies. When a study requires an independent ...

A California-based biotech company is turning heads during Tuesday’s session after the company announced its phase 2b COVID-19 trial received Independent Data Safety Monitoring Board (DSMB ...

Independent Data Safety Monitoring Board (DSMB) recommends study to proceed without modifications based on initial safety assessment of 400 participant 30-day data The company plans to progress ...

Following a positive safety review by the independent Data Safety Monitoring Board (DSMB), which recommended continuation, the PEI's approval allows Cohort 5 to progress to full enrollment.

Following a comprehensive safety review, the independent Data Safety Monitoring Board recommended the trial proceed to the next cohort as planned.The company said, “Safety Confirmed: CELZ-201 ...